Source - GNW

14th September 2016

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Novartis Finance S.A.

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 13th September 2016  BNP Paribas contact: Rupert Lewis telephone: 020 7595 8222 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

Issuer: Novartis Finance S.A.
Guarantor (if any): Novartis AG
Aggregate nominal amount: Euro 1.25 billion

Euro 500 million
Description: 0.125% Notes due 2023

0.625% Notes due 2028
Stabilisation Manager(s): Barclays/BNPP/Deutsche Bank
Offer price: 99.127


This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BNP Paribas Primary New Issues via Globenewswire